LS
Leslie Sloan
Chief Operating Officer at Aeglea Biotherapeutics
View Leslie's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Chief Operating Officer
Present
Company Details
51-200 Employees
With its acquisition of Spyre Therapeutics, Aeglea is shifting its disease focus to inflammatory bowel disease (IBD). Spyre combines best-in-class antibody engineering, rational therapeutic combinations, and precision immunology approaches to maximize efficacy, safety, and convenience of treatments for IBD. For more information, please visit http://aeglea.com.
Year Founded
2013
Social Media
LinkedinFacebookTwitter
Industry
Biotechnology Research
HQ Location
805 Las Cimas Pkwy Suite 100 Austin, Texas 78746, US
Keywords
biotechbiotechnologyrare diseasehuman enzymesengineering enzymes
Discover More About Cleveland Clinic

Find verified contacts of Leslie Sloan in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.